Cardiogenic shock can occur due to acute ischaemic or non-ischaemic cardiac events, or
from progression of long-standing underlying heart disease. When addressing the cause of …

Cardiogenic shock accounts for~ 100,000 annual hospital admissions in the United States.
Despite improvements in medical management strategies, in-hospital mortality remains …

Background Venoarterial extracorporeal membrane oxygenation (VA-ECMO) increases left
ventricular (LV) afterload, potentially provoking LV distention and impairing recovery. LV …

The Impella device (Impella, Abiomed, Danvers, MA) is a percutaneous transvalvular
microaxial flow pump that is currently used for (1) cardiogenic shock,(2) left ventricular …

Cardiogenic shock (CS) is associated with hemodynamic compromise and end-organ
hypoperfusion due to a primary cardiac etiology. In addition to vasoactive medications …

Cardiogenic shock (CS) portends high morbidity and mortality in the contemporary era.
Despite advances in temporary mechanical circulatory supports (MCS), their routine use in …

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) provides temporary cardiac
and respiratory support and has emerged as an established salvage intervention for patients …

Background Percutaneous ventricular assist devices and extracorporeal membrane
oxygenation (ECMO) are increasingly used for mechanical circulatory support (MCS) in …

The main reason for the emergency implantation of venoarterial extracorporeal membrane
oxygenation (VA-ECMO) is the restoration of adequate systemic perfusion, while protecting …

BACKGROUND: Acute myocarditis can result in severe hemodynamic compromise requiring
venoarterial extracorporeal membrane oxygenation (VA-ECMO). Outcomes and factors …